Abstract
Background: Parenteral nutrition-associated cholestasis (PNAC) is a serious complication in preterm infants receiving prolonged parenteral nutrition. Soybean lipid emulsion (SLE) seems to have a role in its pathogenesis, whereas fish oil-based emulsion (FOLE) seems to be able to reverse cholestasis. This study aimed to evaluate the effectiveness of a FOLE in reversing PNAC. Methods: The effectiveness in reversing PNAC was evaluated in prospective cohort study of very preterm infants when compared to historical controls: twenty-six infants (27.0 ± 2.6 weeks GA; 724 ± 204 g) who developed cholestasis while receiving SLE were shifted to receive FOLE and were compared with 30 infants (27.3 ± 2.5 weeks GA 838 ± 277 g) who continued to receive SLE at diagnosis of cholestasis. Results: Time to reversal of cholestasis was the same in the two study groups (45 ± 21 vs 43 ± 32 days). Conclusions: FOLE does not seem to be superior to SLE in reversing cholestasis. Considering that definitive data on the actual efficacy of FOLE to reverse PNAC are lacking, larger randomized trials are required, mainly to asses if FOLE may have a role in PNAC prevention rather than PNAC treatment.
| Original language | English |
|---|---|
| Article number | 101 |
| Journal | Italian Journal of Pediatrics |
| Volume | 44 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Aug 23 2018 |
Fingerprint
Keywords
- Fish oil-based lipid emulsion
- Parenteral nutrition-associated cholestasis
- Preterm infants
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
Cite this
Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated cholestasis. / Costa, Simonetta; Iannotta, Rossella; Maggio, Luca; Barone, Giovanni; Serrao, Francesca; Vento, Giovanni.
In: Italian Journal of Pediatrics, Vol. 44, No. 1, 101, 23.08.2018.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated cholestasis
AU - Costa, Simonetta
AU - Iannotta, Rossella
AU - Maggio, Luca
AU - Barone, Giovanni
AU - Serrao, Francesca
AU - Vento, Giovanni
PY - 2018/8/23
Y1 - 2018/8/23
N2 - Background: Parenteral nutrition-associated cholestasis (PNAC) is a serious complication in preterm infants receiving prolonged parenteral nutrition. Soybean lipid emulsion (SLE) seems to have a role in its pathogenesis, whereas fish oil-based emulsion (FOLE) seems to be able to reverse cholestasis. This study aimed to evaluate the effectiveness of a FOLE in reversing PNAC. Methods: The effectiveness in reversing PNAC was evaluated in prospective cohort study of very preterm infants when compared to historical controls: twenty-six infants (27.0 ± 2.6 weeks GA; 724 ± 204 g) who developed cholestasis while receiving SLE were shifted to receive FOLE and were compared with 30 infants (27.3 ± 2.5 weeks GA 838 ± 277 g) who continued to receive SLE at diagnosis of cholestasis. Results: Time to reversal of cholestasis was the same in the two study groups (45 ± 21 vs 43 ± 32 days). Conclusions: FOLE does not seem to be superior to SLE in reversing cholestasis. Considering that definitive data on the actual efficacy of FOLE to reverse PNAC are lacking, larger randomized trials are required, mainly to asses if FOLE may have a role in PNAC prevention rather than PNAC treatment.
AB - Background: Parenteral nutrition-associated cholestasis (PNAC) is a serious complication in preterm infants receiving prolonged parenteral nutrition. Soybean lipid emulsion (SLE) seems to have a role in its pathogenesis, whereas fish oil-based emulsion (FOLE) seems to be able to reverse cholestasis. This study aimed to evaluate the effectiveness of a FOLE in reversing PNAC. Methods: The effectiveness in reversing PNAC was evaluated in prospective cohort study of very preterm infants when compared to historical controls: twenty-six infants (27.0 ± 2.6 weeks GA; 724 ± 204 g) who developed cholestasis while receiving SLE were shifted to receive FOLE and were compared with 30 infants (27.3 ± 2.5 weeks GA 838 ± 277 g) who continued to receive SLE at diagnosis of cholestasis. Results: Time to reversal of cholestasis was the same in the two study groups (45 ± 21 vs 43 ± 32 days). Conclusions: FOLE does not seem to be superior to SLE in reversing cholestasis. Considering that definitive data on the actual efficacy of FOLE to reverse PNAC are lacking, larger randomized trials are required, mainly to asses if FOLE may have a role in PNAC prevention rather than PNAC treatment.
KW - Fish oil-based lipid emulsion
KW - Parenteral nutrition-associated cholestasis
KW - Preterm infants
UR - http://www.scopus.com/inward/record.url?scp=85052121598&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052121598&partnerID=8YFLogxK
U2 - 10.1186/s13052-018-0539-0
DO - 10.1186/s13052-018-0539-0
M3 - Article
C2 - 30139361
AN - SCOPUS:85052121598
VL - 44
JO - Italian Journal of Pediatrics
JF - Italian Journal of Pediatrics
SN - 1720-8424
IS - 1
M1 - 101
ER -